tradingkey.logo

Butterfly Network Inc

BFLY

1.435USD

+0.035+2.50%
Horário de mercado ETCotações atrasadas em 15 min
360.24MValor de mercado
PerdaP/L TTM

Butterfly Network Inc

1.435

+0.035+2.50%
Mais detalhes de Butterfly Network Inc Empresa
Butterfly Network, Inc. is a digital health company. The Company is focused on transforming care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. It has two portable ultrasound devices on the market: second-generation Butterfly iQ+ and third-generation Butterfly iQ3. Butterfly iQ+/iQ3 are both powered by its Ultrasound-on-Chip technology, allowing them to power whole-body imaging on a single handheld probe using digital semiconductor technology. It offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Within the Butterfly application, users can utilize up to six imaging modes, including B-Mode, Color Doppler, M-Mode, Power Doppler, Pulsed-Wave Doppler, and Biplane Imaging.
Informações da empresa
Código da empresaBFLY
Nome da EmpresaButterfly Network Inc
Data de listagemMay 26, 2020
CEODr. Joseph M. (Joe) Devivo
Número de funcionários190
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 26
Endereço1600 District Avenue
CidadeBURLINGTON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal01803
Telefone17815574800
Sitehttps://www.butterflynetwork.com/
Código da empresaBFLY
Data de listagemMay 26, 2020
CEODr. Joseph M. (Joe) Devivo
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jonathan M. Rothberg, Ph.D.
Dr. Jonathan M. Rothberg, Ph.D.
Director
Director
9.65M
+0.84%
Dr. Joseph M. (Joe) Devivo
Dr. Joseph M. (Joe) Devivo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.43M
+67.94%
Mr. Steve Cashman
Mr. Steve Cashman
Chief Business Officer
Chief Business Officer
502.59K
-77.90%
Mr. Larry Robbins
Mr. Larry Robbins
Lead Independent Director
Lead Independent Director
365.50K
+187.40%
Ms. Dawn Carfora
Ms. Dawn Carfora
Independent Director
Independent Director
219.62K
+57.79%
Dr. Andrei G. Stoica, Ph.D.
Dr. Andrei G. Stoica, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Dr. Elazer Edelman, M.D., Ph.D.
Dr. Elazer Edelman, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Erica G. Schwartz, M.D., J.D.
Dr. Erica G. Schwartz, M.D., J.D.
Independent Director
Independent Director
--
--
Ms. S. Louise Phanstiel, CPA
Ms. S. Louise Phanstiel, CPA
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jonathan M. Rothberg, Ph.D.
Dr. Jonathan M. Rothberg, Ph.D.
Director
Director
9.65M
+0.84%
Dr. Joseph M. (Joe) Devivo
Dr. Joseph M. (Joe) Devivo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.43M
+67.94%
Mr. Steve Cashman
Mr. Steve Cashman
Chief Business Officer
Chief Business Officer
502.59K
-77.90%
Mr. Larry Robbins
Mr. Larry Robbins
Lead Independent Director
Lead Independent Director
365.50K
+187.40%
Ms. Dawn Carfora
Ms. Dawn Carfora
Independent Director
Independent Director
219.62K
+57.79%
Dr. Andrei G. Stoica, Ph.D.
Dr. Andrei G. Stoica, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
Por EmpresaUSD
Nome
Receita
Proporção
Hardware
14.16M
66.73%
Software and other services
7.06M
33.27%
Por RegiãoUSD
Nome
Receita
Proporção
United States
17.04M
80.28%
International
4.19M
19.72%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Hardware
14.16M
66.73%
Software and other services
7.06M
33.27%
Distribuição de ações
Atualizado em: qui, 22 de mai
Atualizado em: qui, 22 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Fosun International Ltd
4.85%
Glenview Capital Management, LLC
4.51%
Rothberg (Jonathan M)
4.37%
The Vanguard Group, Inc.
3.88%
Capital Research Global Investors
3.84%
Other
78.55%
Investidores
Investidores
Proporção
Fosun International Ltd
4.85%
Glenview Capital Management, LLC
4.51%
Rothberg (Jonathan M)
4.37%
The Vanguard Group, Inc.
3.88%
Capital Research Global Investors
3.84%
Other
78.55%
Tipos de investidores
Investidores
Proporção
Investment Advisor
24.01%
Hedge Fund
10.38%
Investment Advisor/Hedge Fund
8.67%
Individual Investor
6.98%
Holding Company
4.85%
Corporation
2.06%
Research Firm
2.03%
Foundation
0.46%
Pension Fund
0.31%
Other
40.26%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
452
132.08M
59.80%
+19.64M
2025Q1
463
134.83M
61.70%
+30.88M
2024Q4
439
95.60M
44.26%
+1.75M
2024Q3
436
81.98M
42.82%
-15.90M
2024Q2
437
84.70M
45.43%
-25.58M
2024Q1
443
102.66M
55.89%
-10.36M
2023Q4
445
101.26M
55.91%
-15.86M
2023Q3
456
105.48M
58.39%
-19.66M
2023Q2
472
110.05M
61.35%
-5.29M
2023Q1
486
98.46M
55.67%
-23.16M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Fosun International Ltd
10.72M
4.85%
--
--
Mar 31, 2025
Glenview Capital Management, LLC
9.96M
4.51%
--
--
Jun 13, 2025
Rothberg (Jonathan M)
9.65M
4.37%
+80.43K
+0.84%
Jun 13, 2025
The Vanguard Group, Inc.
8.57M
3.88%
+1.13M
+15.21%
Mar 31, 2025
Capital Research Global Investors
8.49M
3.84%
+7.13M
+524.60%
Mar 31, 2025
Capital World Investors
8.49M
3.84%
+7.13M
+524.60%
Mar 31, 2025
ARK Investment Management LLC
7.02M
3.18%
+1.01M
+16.84%
Mar 31, 2025
First Light Asset Management, LLC
5.51M
2.49%
+1.51M
+37.83%
Mar 31, 2025
Hood River Capital Management LLC
4.95M
2.24%
+4.95M
--
Mar 31, 2025
Longview Investors LLC
4.55M
2.06%
--
--
Jun 13, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
ARK Genomic Revolution ETF
1.23%
SPDR S&P Health Care Equipment ETF
0.81%
Global X HealthTech ETF
0.37%
SPDR S&P Kensho New Economies Composite ETF
0.16%
iShares Micro-Cap ETF
0.09%
iShares U.S. Medical Devices ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 Growth ETF
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.03%
Global X Russell 2000 ETF
0.02%
Ver Mais
ARK Genomic Revolution ETF
Proporção1.23%
SPDR S&P Health Care Equipment ETF
Proporção0.81%
Global X HealthTech ETF
Proporção0.37%
SPDR S&P Kensho New Economies Composite ETF
Proporção0.16%
iShares Micro-Cap ETF
Proporção0.09%
iShares U.S. Medical Devices ETF
Proporção0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.03%
iShares Russell 2000 Growth ETF
Proporção0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporção0.03%
Global X Russell 2000 ETF
Proporção0.02%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI